SAMUEL HALL: Open Payments
NPI 1194384602 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 130 payments from 21 companies in 2025. Trend: 2023 $1,335 · 2024 $2,256 · 2025 $1,892
Food & beverage: $1,892
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $276 |
| ABBVIE INC. | 23 | $271 |
| PFIZER INC. | 14 | $188 |
| Abbott Laboratories | 10 | $183 |
| AstraZeneca Pharmaceuticals LP | 5 | $165 |
| Lilly USA, LLC | 11 | $155 |
| Amgen Inc. | 10 | $144 |
| Phathom Pharmaceuticals, Inc. | 7 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Astellas Pharma US Inc | 2 | $54 |
Products named: FREESTYLE LIBRE, Ozempic, NURTEC ODT, MOUNJARO, OTEZLA, UBRELVY, FARXIGA, Wegovy.
Industry payments across TX — which companies pay providers there.
